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T he majority of glomus tumors occur in the dermis orsubcutis of the extremities. It is extremely rare in thetracheobronchial tree: only 16 cases have been reportedin the literature.1 Although glomus tumors are predom-
inantly benign, they rarely demonstrate an aggressive and malig-
nant clinical course and histologic characteristics. Herein we dis-
cuss a patient with a tracheal glomus tumor classified as “uncertain
malignant potential” according to the new World Health Organi-
zation (WHO) classification.
Clinical Summary
An 83-year-old woman presenting with hemoptysis and dyspnea
was admitted to our hospital. She had a 3-month history of cough
and progressive dyspnea. The results of chest roentgenography
were normal. On physical
examination, she had cyano-
sis and inspiratory-expiratory
wheezing. Pulmonary func-
tion tests showed a forced vital capacity of 0.4 L (27%) and a
forced expiratory volume in 1 second/forced vital capacity ratio of
73%. Arterial blood gas analysis on room air breathing showed a
PO2 of 40.1 mm Hg, a PCO2 of 42.7 mm Hg, and a pH of 7.41, and
oxygen saturation was 75.6%. A thorax computed tomographic
scan revealed a 1-cm polypoid soft tissue lesion arising from the
posterolateral wall and occupying 80% of the lumen of the upper
third of the trachea (Figure 1). Rigid bronchoscopy showed a
mobile polypoid mass arising from the right posterolateral tracheal
wall 5 cm below the vocal cord, occupying 80% of the tracheal
lumen. Through a right minithoracotomy, the lesion, palpated
above the azygos vein, was resected with its peduncle by means of
partial sleeve resection. The trachea was repaired primarily with
nonabsorbable sutures (Figure 1).
The surgical specimen was a sessile, solid polypoid tumor of
2.0  1.5  1.2 cm. Microscopically, the tumor was composed of
sheets and trabeculae of round to polygonal cells with eosinophilic
cytoplasm and indistinct cell borders interspersed with various-
sized vessels. At the periphery of the mass, the cytologic features
of the tumor cells resembled benign glomus tumor. At the center
of the mass, the neoplastic cells exhibited moderate nuclear atypia
and increased mitotic activity (4 mitoses per 50 high-power fields,
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Figure 1. Thorax computed tomo-
graphic scan revealed a 1-cm
polypoid soft tissue lesion occu-
pying the lumen of the trachea.
Intraoperative view of the endo-
tracheal lesion. SVC, superior
vena cava.
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Figure 2). There was no necrosis, atypical mitotic figure, or vas-
cular space involvement. The tumor cells were immunoreactive
with -smooth muscle actin and vimentin but were negative with
S-100 protein, pancytokeratin, epithelial membrane antigen (EMA),
CD34, desmin, chromogranin, and neuron-specific enolase (NSE).
On the fifth postoperative day, the patient was dismissed from the
hospital without any complications. She was asymptomatic for 12
months after the operation.
Discussion
Glomus tumors, known as benign tumors, first described by Mason
in 1924, typically involve the skin of the hand and especially the
subungual region of the finger. They are extremely rare in the
trachea.
The benign form accounts for more than 95% of these lesions.
Folpe and colleagues2 proposed a new classification of atypical
and malignant glomus tumors after survey of 52 unusual glomus
tumors. According to the new WHO classification of glomus tumors
based on the study of Folpe and colleagues,3 glomus tumors with
atypical features are divided into 4 categories: malignant glomus
tumor, glomus tumor with nuclear atypia only, glomus tumor of
uncertain malignant potential, and glomangiomatosis. It is men-
tioned that the diagnosis of malignant glomus tumor should be
reserved for tumors showing (1) size of greater than 2 cm and
subfascial or visceral location, (2) atypical mitotic figures, or
(3) marked nuclear atypia and any level of mitotic activity, and
also glomus tumors not fulfilling criteria for malignancy but hav-
ing at least one atypical feature other than nuclear pleomorphism
should be diagnosed as a “glomus tumor of uncertain malignant
potential.”3
The tumor presented here has characteristic features of a
benign-appearing typical glomus tumor at the periphery of the
mass (and this is the most important clue for the diagnosis2) but
also has some atypical histomorphologic features (eg, moderate
nuclear atypia), mitotic activity, and unusual clinical features (eg,
deep location). These criteria do not meet the minimum definition
of malignant glomus tumor according to the new WHO classifi-
cation but are consistent with the diagnosis of glomus tumor of
uncertain malign potential.
The diagnosis of tracheobronchial glomus tumors can be elu-
sive. It is necessary to differentiate from carcinoid tumors and
hemangiopericytomas.4 Immunohistochemically, smooth muscle
actin expression and abundant pericellular type 4 collagen produc-
tion confirm the diagnosis of glomus tumor.3
Folpe and colleagues2 mention that none of their patients in this
category experienced an adverse event, but this label will evoke
close follow-up care. Sleeve resection with primary reconstruction
is the treatment of choice for glomus tumors. Bronchoscopic
tracheal stenting or laser resection with or without adjuvant radio-
therapy should be reserved for patients with inoperable tumors.5
Complete surgical resection is curative and requires no further
treatment.
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Figure 2. Tracheal tumor infiltrating the subepithelial glandular
structures (hematoxylin and eosin, original magnification 40)
and moderate nuclear atypia and increased mitotic activity (he-
matoxylin and eosin, original magnification 400).
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